The Feasibility of a Prehabilitation Program in the Liver Transplant Population at Barnes-Jewish Hospital
- Conditions
- Physical ActivityEnd Stage Liver Disease
- Interventions
- Procedure: Exercise
- Registration Number
- NCT02444273
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
The primary outcome of this study is to demonstrate the feasibility of a prehabilitation program at Barnes Jewish Hospital for liver transplant candidates. Those patients who consent to participate in the study and are placed on the transplant list will be randomized into either the control or intervention group. The intervention group receives a personalized home exercise program along with weekly phone calls to provide coaching, mentoring and motivation. Data collected at baseline, post-transplant and, post-transplant follow up will be compared among the two study groups. The secondary outcomes include: normative data of functional measures for patients with end stage liver disease and to determine the effect size for future research on prehabilitation in the patient population.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 101
- Being evaluated for liver transplantation by Barnes Jewish Hospital medical team
- Non-english speaking
- Medical contraindications to exercise as determined by the medical team
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Exercise Group Exercise Subjects will receive a personalized home exercise program and regular phone calls from a therapist to monitor and promote activity.
- Primary Outcome Measures
Name Time Method Feasibility of a prehabilitation program. 2 Years Feasibility will be measured by participation and outcome assessment measures.
- Secondary Outcome Measures
Name Time Method Normative data on 10 meter walk for patients with end stage liver disease. Baseline Normative data on Timed Up and Go for patients with end stage liver disease. Baseline Normative data on Modified Dynamic Gait Index for patients with end stage liver disease. Baseline Normative data on Five Time Sit to Stand for patients with end stage liver disease. Baseline Normative data on 6 Minute Walk Test for patients with end stage liver disease. Baseline